Susan Chi

Susan Chi is an Associate Professor of Pediatrics at Harvard Medical School and serves as the Clinical Director of the Brain Tumor Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. She is an Attending Physician in the Dana-Farber/Boston Children's Blood Disorders Center.

• Undergraduate: Princeton University (1990)
• Medical School: Mt. Sinai School of Medicine (1994)
• Residency: Yale-New Haven Children's Hospital (1998)
• Fellowships: Memorial Sloan-Kettering Cancer Center (2001), New York University Medical Center (2002)

Dr. Chi's research focuses on pediatric brain tumors, particularly atypical teratoid rhabdoid tumors (ATRT), high-grade gliomas, and choroid plexus tumors. She explores precision medicine, targeted therapies, and immunotherapy in clinical trials. Her work includes molecular profiling of tumors, novel chemotherapeutic regimens, and biological insights for pediatric neuro-oncology. Recent publications highlight oncogenic microRNAs, SMARCB1 mutations, and RAF inhibitors in pediatric low-grade glioma.

Her articles since 2023 emphasize targeted therapies (e.g., tovorafenib, ribociclib), precision trials (e.g., NCI-COG pediatric MATCH), and molecular profiling for DNA repair defects. Subfields include angiogenesis inhibition, epigenetic therapy, immune checkpoint modulation, genetic tumor drivers, metronomic chemotherapy, and pediatric oncology.

Key affiliations include Dana-Farber Cancer Institute, Boston Children's Hospital, and Harvard Medical School. She has held leadership roles in pediatric neuro-oncology and participated in multi-institutional clinical trials for brain tumors.